{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:07:40Z","timestamp":1790064460042,"version":"4.0.1"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004204","name":"Tongji University","doi-asserted-by":"publisher","award":["2026-0555-YB-05"],"award-info":[{"award-number":["2026-0555-YB-05"]}],"id":[{"id":"10.13039\/501100004204","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["PWZxq2022-03 \\u3001 PW2023D-14"],"award-info":[{"award-number":["PWZxq2022-03 \\u3001 PW2023D-14"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFA0917700"],"award-info":[{"award-number":["2024YFA0917700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008750","name":"Shanghai Municipal Hospital Development Center","doi-asserted-by":"publisher","award":["2022SKLY-12"],"award-info":[{"award-number":["2022SKLY-12"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008750","name":"Shanghai Municipal Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC12022106"],"award-info":[{"award-number":["SHDC12022106"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272888"],"award-info":[{"award-number":["82272888"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["25TS1412200"],"award-info":[{"award-number":["25TS1412200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.mtbio.2026.103192","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T14:56:50Z","timestamp":1777733810000},"page":"103192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Engineered artificial antigen-presenting cells for tumor immunotherapy: Design strategies, clinical applications, and translational challenges"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5379-2634","authenticated-orcid":false,"given":"Haojie","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6289-4271","authenticated-orcid":false,"given":"Yaqian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8012-7954","authenticated-orcid":false,"given":"Yongsong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2060-0276","authenticated-orcid":false,"given":"Jiani","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6053-0570","authenticated-orcid":false,"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5817-7309","authenticated-orcid":false,"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1073-783X","authenticated-orcid":false,"given":"Hui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4703-573X","authenticated-orcid":false,"given":"Shanshan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8683-6196","authenticated-orcid":false,"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.mtbio.2026.103192_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103192_bib2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","article-title":"Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019","volume":"8","author":"Kocarnik","year":"2022","journal-title":"JAMA Oncol."},{"issue":"10","key":"10.1016\/j.mtbio.2026.103192_bib3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrendo.2011.140","article-title":"Advances in surgical therapy for thyroid cancer","volume":"7","author":"Mazeh","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103192_bib4","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1200\/JCO.22.00046","article-title":"Preoperative chemotherapy for operable Colon cancer: mature results of an international randomized controlled trial","volume":"41","author":"Morton","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.mtbio.2026.103192_bib5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nrclinonc.2015.120","article-title":"Opportunities and challenges of radiotherapy for treating cancer","volume":"12","author":"Schaue","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"22","key":"10.1016\/j.mtbio.2026.103192_bib6","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1182\/blood-2008-10-187237","article-title":"Toward a stem cell gene therapy for breast cancer","volume":"113","author":"Li","year":"2009","journal-title":"Blood"},{"issue":"S1","key":"10.1016\/j.mtbio.2026.103192_bib7","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/ajh.25418","article-title":"An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer","volume":"94","author":"Feins","year":"2019","journal-title":"Am. J. Hematol."},{"issue":"18","key":"10.1016\/j.mtbio.2026.103192_bib8","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1016\/j.cell.2024.06.027","article-title":"Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis","volume":"187","author":"Wang","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103192_bib9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01489-2","article-title":"Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions","volume":"21","author":"Yi","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103192_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jaci.2022.10.011","article-title":"From thymus to tissues and tumors: a review of T-cell biology","volume":"151","author":"Chopp","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"issue":"9","key":"10.1016\/j.mtbio.2026.103192_bib11","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nm1100","article-title":"Cancer immunotherapy: moving beyond current vaccines","volume":"10","author":"Rosenberg","year":"2004","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103192_bib12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41563-020-0793-6","article-title":"A DNA nanodevice-based vaccine for cancer immunotherapy","volume":"20","author":"Liu","year":"2021","journal-title":"Nat. Mater."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103192_bib13","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/s41467-018-03915-4","article-title":"A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors","volume":"9","author":"Wang","year":"2018","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.mtbio.2026.103192_bib14","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/nnano.2017.113","article-title":"Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy","volume":"12","author":"Min","year":"2017","journal-title":"Nat. Nanotechnol."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103192_bib15","doi-asserted-by":"crossref","first-page":"7392","DOI":"10.1021\/nn403158n","article-title":"Ex vivo programming of dendritic cells by mitochondria-targeted nanoparticles to produce interferon-gamma for cancer immunotherapy","volume":"7","author":"Marrache","year":"2013","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.mtbio.2026.103192_bib16","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.4049\/jimmunol.170.4.2161","article-title":"Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patients","volume":"170","author":"Meidenbauer","year":"2003","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.mtbio.2026.103192_bib17","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nm869","article-title":"Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cells","volume":"9","author":"Oelke","year":"2003","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.mtbio.2026.103192_bib18","doi-asserted-by":"crossref","first-page":"10724","DOI":"10.1021\/acsnano.7b04955","article-title":"Biomimetic magnetosomes as versatile artificial antigen-presenting cells to potentiate T-Cell-Based anticancer therapy","volume":"11","author":"Zhang","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2026.103192_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.biomaterials.2016.11.038","article-title":"Biomimetic biodegradable artificial antigen presenting cells synergize with PD-1 blockade to treat melanoma","volume":"118","author":"Kosmides","year":"2017","journal-title":"Biomaterials"},{"issue":"80","key":"10.1016\/j.mtbio.2026.103192_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002207","article-title":"Establishment of antitumor memory in humans using in vitro-educated CD8+ T cells","volume":"3","author":"Butler","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103192_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nbt0202-143","article-title":"Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB","volume":"20","author":"Maus","year":"2002","journal-title":"Nat. Biotechnol."},{"issue":"5","key":"10.1016\/j.mtbio.2026.103192_bib23","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/mt.sj.6300134","article-title":"Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules","volume":"15","author":"Suhoski","year":"2007","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103192_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000990","article-title":"Cell-based artificial APC resistant to lentiviral transduction for efficient generation of CAR-T cells from various cell sources","volume":"8","author":"Schmidts","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"6","key":"10.1016\/j.mtbio.2026.103192_bib25","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1158\/1078-0432.CCR-06-1905","article-title":"Long-lived antitumor CD8+ lymphocytes for adoptive therapy generated using an artificial antigen-presenting cell","volume":"13","author":"Butler","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"22","key":"10.1016\/j.mtbio.2026.103192_bib26","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1158\/1078-0432.CCR-13-3451","article-title":"Activating and propagating polyclonal gamma delta T cells with broad specificity for malignancies","volume":"20","author":"Deniger","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"22","key":"10.1016\/j.mtbio.2026.103192_bib27","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1158\/1078-0432.CCR-13-3464","article-title":"Neuroblastoma killing properties of V\u03b42 and V\u03b42-negative \u03b3\u03b4T cells following expansion by artificial antigen-presenting cells","volume":"20","author":"Fisher","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"16","key":"10.1016\/j.mtbio.2026.103192_bib28","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.1158\/1078-0432.CCR-10-3083","article-title":"Induction of HLA-DP4-restricted anti-survivin Th1 and Th2 responses using an artificial antigen-presenting cell","volume":"17","author":"Tanaka","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mtbio.2026.103192_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216287","article-title":"Co-infusion of CAR T cells with aAPCs expressing chemokines and costimulatory ligands enhances the anti-tumor efficacy in mice","volume":"568","author":"Li","year":"2023","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103192_bib30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/CJI.0000000000000445","article-title":"Large scale Ex vivo expansion of \u03b3\u03b4 T cells using artificial antigen-presenting cells","volume":"46","author":"Boucher","year":"2023","journal-title":"J. Immunother."},{"issue":"9","key":"10.1016\/j.mtbio.2026.103192_bib31","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/CJI.0000000000000056","article-title":"Activation and propagation of tumor-infiltrating lymphocytes on clinical-grade designer artificial antigen-presenting cells for adoptive immunotherapy of melanoma","volume":"37","author":"Forget","year":"2014","journal-title":"J. Immunother."},{"issue":"10","key":"10.1016\/j.mtbio.2026.103192_bib32","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1038\/sj.leu.2404329","article-title":"Characterization of an artificial antigen-presenting cell to propagate cytolytic CD19-specific T cells","volume":"20","author":"Numbenjapon","year":"2006","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.mtbio.2026.103192_bib33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/CJI.0000000000000306","article-title":"Generation of antitumor T cells for adoptive cell therapy with artificial antigen presenting cells","volume":"43","author":"Shrestha","year":"2020","journal-title":"J. Immunother."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103192_bib34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jcyt.2013.08.008","article-title":"Genetically engineered fixed K562 cells: potent \"off-the-shelf\" antigen-presenting cells for generating virus-specific T cells","volume":"16","author":"Tanimoto","year":"2014","journal-title":"Cytotherapy"},{"issue":"3","key":"10.1016\/j.mtbio.2026.103192_bib35","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/clim.2002.5277","article-title":"A cell-based artificial antigen-presenting cell coated with anti-CD3 and CD28 antibodies enables rapid expansion and long-term growth of CD4 T lymphocytes","volume":"105","author":"Thomas","year":"2002","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103192_bib36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2567.2004.01853.x","article-title":"Murine CD8 lymphocyte expansion in vitro by artificial antigen-presenting cells expressing CD137L (4-1BBL) is superior to CD28, and CD137L expressed on neuroblastoma expands CD8 tumour-reactive effector cells in vivo","volume":"112","author":"Yan","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.mtbio.2026.103192_bib37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1479-5876-9-131","article-title":"Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes","volume":"9","author":"Ye","year":"2011","journal-title":"J. Transl. Med."},{"issue":"7","key":"10.1016\/j.mtbio.2026.103192_bib38","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1182\/blood-2003-02-0345","article-title":"Rapid expansion of cytomegalovirus-specific cytotoxic T lymphocytes by artificial antigen-presenting cells expressing a single HLA allele","volume":"102","author":"Papanicolaou","year":"2003","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.mtbio.2026.103192_bib39","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1158\/0008-5472.CAN-04-2991","article-title":"Artificial antigen-presenting cells transduced with telomerase efficiently expand epitope-specific, human leukocyte antigen-restricted cytotoxic T cells","volume":"65","author":"Dupont","year":"2005","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.mtbio.2026.103192_bib40","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/icb.2016.25","article-title":"Artificial antigen-presenting cells expressing HLA class II molecules as an effective tool for amplifying human specific memory CD4+ T cells","volume":"94","author":"Garnier","year":"2016","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.mtbio.2026.103192_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.674276","article-title":"Generation of pure highly functional human anti-tumor specific cytotoxic T lymphocytes with stem cell-like memory features for melanoma immunotherapy","volume":"12","author":"Hamieh","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.mtbio.2026.103192_bib42","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.4049\/jimmunol.0804178","article-title":"A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy","volume":"183","author":"Hasan","year":"2009","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.mtbio.2026.103192_bib43","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1440-1711.2006.01462.x","article-title":"Efficient priming and expansion of antigen-specific CD8+ T cells by a novel cell-based artificial APC","volume":"84","author":"Sasawatari","year":"2006","journal-title":"Immunol. Cell Biol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103192_bib44","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1038\/s41467-021-22898-3","article-title":"Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"issue":"40","key":"10.1016\/j.mtbio.2026.103192_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201701864","article-title":"Surface-engineering of red blood cells as artificial antigen presenting cells promising for cancer immunotherapy","volume":"13","author":"Sun","year":"2017","journal-title":"Small"},{"issue":"17","key":"10.1016\/j.mtbio.2026.103192_bib46","doi-asserted-by":"crossref","first-page":"7634","DOI":"10.1021\/jacs.1c09316","article-title":"DNA engineered lymphocyte-based homologous targeting artificial antigen-presenting cells for personalized cancer immunotherapy","volume":"144","author":"Sun","year":"2022","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103192_bib21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/imr.12129","article-title":"Human cell-based artificial antigen-presenting cells for cancer immunotherapy","volume":"257","author":"Butler","year":"2014","journal-title":"Immunol. Rev."},{"issue":"30","key":"10.1016\/j.mtbio.2026.103192_bib47","article-title":"Facile transformation of murine and human primary dendritic cells into robust and modular artificial antigen-presenting systems by intracellular hydrogelation","volume":"33","author":"Lin","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2026.103192_bib48","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3389\/fimmu.2019.00448","article-title":"Bystander T-Cells support clonal T-Cell activation by controlling the release of dendritic cell-derived immune-stimulatory extracellular vesicles","volume":"10","author":"Lindenbergh","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mtbio.2026.103192_bib49","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jconrel.2022.11.053","article-title":"Dendritic cell derived exosomes loaded neoantigens for personalized cancer immunotherapies","volume":"353","author":"Li","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103192_bib50","article-title":"Enhanced tumor immunotherapy by nanovesicles derived from engineered DC-like M1 macrophage","author":"Jiang","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"36","key":"10.1016\/j.mtbio.2026.103192_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303080","article-title":"A personalized cancer vaccine that induces synergistic innate and adaptive immune responses","volume":"35","author":"Kuen","year":"2023","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103192_bib52","first-page":"205","article-title":"Dendritic cell-derived exosomes stimulate stronger CD8+ CTL responses and antitumor immunity than tumor cell-derived exosomes","volume":"3","author":"Hao","year":"2006","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103192_bib53","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3892\/ijo.2015.2993","article-title":"Exosomes derived from IL-12-anchored renal cancer cells increase induction of specific antitumor response in vitro: a novel vaccine for renal cell carcinoma","volume":"36","author":"Zhang","year":"2010","journal-title":"Int. J. Oncol."},{"issue":"11","key":"10.1016\/j.mtbio.2026.103192_bib54","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.3390\/vaccines10111877","article-title":"Limited T-Cell-Stimulating effect of Cytochalasin-B-Induced membrane vesicles isolated from artificial antigen-presenting cells","volume":"10","author":"Kim","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103192_bib55","doi-asserted-by":"crossref","first-page":"8121","DOI":"10.1038\/s41467-024-52104-z","article-title":"Tuning the fluidity and protein Corona of ultrasound-responsive liposomal nanovaccines to program T cell immunity in mice","volume":"15","author":"He","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103192_bib56","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1038\/s41467-023-39607-x","article-title":"Ultrasound-responsive low-dose doxorubicin liposomes trigger mitochondrial DNA release and activate cGAS-STING-mediated antitumour immunity","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.mtbio.2026.103192_bib57","article-title":"Cell-sized lipid vesicles as artificial antigen-presenting cells for antigen-specific T cell activation","volume":"12","author":"Chen","year":"2023","journal-title":"Adv. Healthcare Mater."},{"issue":"6","key":"10.1016\/j.mtbio.2026.103192_bib58","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.4049\/jimmunol.174.6.3204","article-title":"Clustering of T cell ligands on artificial APC membranes influences T cell activation and protein kinase C theta translocation to the T cell plasma membrane","volume":"174","author":"Giannoni","year":"2005","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.mtbio.2026.103192_bib59","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3324\/haematol.12521","article-title":"The effect of artificial antigen-presenting cells with preclustered anti-CD28\/-CD3\/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells","volume":"93","author":"Zappasodi","year":"2008","journal-title":"Haematologica"},{"issue":"26","key":"10.1016\/j.mtbio.2026.103192_bib60","article-title":"Antigen presenting cell mimetic lipid nanoparticles for rapid mRNA CAR T cell cancer immunotherapy","volume":"36","author":"Metzloff","year":"2024","journal-title":"Adv. Mater."},{"issue":"13","key":"10.1016\/j.mtbio.2026.103192_bib62","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/smll.201402369","article-title":"Biodegradable nanoellipsoidal artificial antigen presenting cells for antigen specific T-cell activation","volume":"11","author":"Meyer","year":"2015","journal-title":"Small"},{"key":"10.1016\/j.mtbio.2026.103192_bib64","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.actbio.2023.02.023","article-title":"Shape matters: biodegradable anisotropic nanoparticle artificial antigen presenting cells for cancer immunotherapy","volume":"160","author":"Ben-Akiva","year":"2023","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103192_bib68","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.biomaterials.2013.09.050","article-title":"Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells","volume":"35","author":"Sunshine","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.mtbio.2026.103192_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.628059","article-title":"Nanoparticles engineered as artificial antigen-presenting cells induce human CD4+ and CD8+ tregs that are functional in humanized mice","volume":"12","author":"Giang","year":"2021","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.mtbio.2026.103192_bib75","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00262-017-2016-9","article-title":"Paracrine release of IL-2 and anti-CTLA-4 enhances the ability of artificial polymer antigen-presenting cells to expand antigen-specific T cells and inhibit tumor growth in a mouse model","volume":"66","author":"Zhang","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"issue":"7","key":"10.1016\/j.mtbio.2026.103192_bib76","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1158\/2326-6066.CIR-18-0881","article-title":"An artificial antigen-presenting cell delivering 11 immune molecules expands tumor antigen-specific CTLs in Ex vivo and in vivo Murine melanoma models","volume":"7","author":"Zhang","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.mtbio.2026.103192_bib77","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.2147\/IJN.S195828","article-title":"PEGylated and CD47-conjugated nanoellipsoidal artificial antigen-presenting cells minimize phagocytosis and augment anti-tumor T-cell responses","volume":"14","author":"Song","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103192_bib78","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.bbrc.2011.06.164","article-title":"A novel system of artificial antigen-presenting cells efficiently stimulates flu peptide-specific cytotoxic T cells in vitro","volume":"411","author":"Han","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.mtbio.2026.103192_bib79","doi-asserted-by":"crossref","first-page":"7913","DOI":"10.1021\/acsami.0c19955","article-title":"Biodegradable cationic polymer blends for fabrication of enhanced artificial antigen presenting cells to treat melanoma","volume":"13","author":"Rhodes","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"24","key":"10.1016\/j.mtbio.2026.103192_bib80","doi-asserted-by":"crossref","first-page":"7329","DOI":"10.1158\/1078-0432.CCR-07-1025","article-title":"HLA tetramer based artificial antigen-presenting cells efficiently stimulate CTLs specific for malignant glioma","volume":"13","author":"Jiang","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103192_bib81","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1745-7270.2006.00150.x","article-title":"Induction of the epstein-barr virus latent membrane protein 2 antigen-specific cytotoxic T lymphocytes using human leukocyte antigen tetramer-based artificial antigen-presenting cells","volume":"38","author":"Lu","year":"2006","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103192_bib82","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.canlet.2007.07.015","article-title":"Generation of allo-restricted cytotoxic T lymphocytes against malignant glioma by artificial antigen-presenting cells","volume":"256","author":"Lu","year":"2007","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103192_bib83","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.canlet.2008.05.049","article-title":"Adoptive transfer of pTRP2-specific CTLs expanding by bead-based artificial antigen-presenting cells mediates anti-melanoma response","volume":"271","author":"Lu","year":"2008","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.mtbio.2026.103192_bib84","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00262-008-0573-7","article-title":"In vivo anti-melanoma efficacy of allo-restricted CTLs specific for melanoma expanded by artificial antigen-presenting cells","volume":"58","author":"Lu","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103192_bib85","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1182\/blood-2003-07-2461","article-title":"Artificial antigen-presenting constructs efficiently stimulate minor histocompatibility antigen-specific cytotoxic T lymphocytes","volume":"104","author":"Oosten","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103192_bib86","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.cellimm.2007.07.002","article-title":"Induction of tumor antigen-specific cytotoxic T cell responses in na\u00efve mice by latex microspheres-based artificial antigen-presenting cell constructs","volume":"247","author":"Shen","year":"2007","journal-title":"Cell. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.mtbio.2026.103192_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2013.01.003","article-title":"Latex bead-based artificial antigen-presenting cells induce tumor-specific CTL responses in the native T-cell repertoires and inhibit tumor growth","volume":"150","author":"Shen","year":"2013","journal-title":"Immunol. Lett."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103192_bib88","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1158\/0008-5472.CAN-07-5796","article-title":"Synthetic CD4+ T cell-targeted antigen-presenting cells elicit protective antitumor responses","volume":"68","author":"Caserta","year":"2008","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103192_bib89","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00262-008-0542-1","article-title":"In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC)","volume":"58","author":"Durai","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.mtbio.2026.103192_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.994532","article-title":"Standardized in-vitro evaluation of CAR-T cells using acellular artificial target particles","volume":"13","author":"Harari-Steinfeld","year":"2022","journal-title":"Front. Immunol."},{"issue":"13","key":"10.1016\/j.mtbio.2026.103192_bib91","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1158\/1078-0432.CCR-19-3487","article-title":"Rapid expansion of highly functional antigen-specific T cells from patients with melanoma by nanoscale artificial antigen-presenting cells","volume":"26","author":"Ichikawa","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"50","key":"10.1016\/j.mtbio.2026.103192_bib92","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adm7928","article-title":"Ex vivo expansion and hydrogel-mediated in vivo delivery of tissue-resident memory T cells for immunotherapy","volume":"10","author":"Li","year":"2024","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103192_bib93","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1521-6616(02)00017-7","article-title":"HLA tetramer-based artificial antigen-presenting cells for stimulation of CD4+ T cells","volume":"106","author":"Maus","year":"2003","journal-title":"Clin. Immunol."},{"issue":"24","key":"10.1016\/j.mtbio.2026.103192_bib94","doi-asserted-by":"crossref","first-page":"9376","DOI":"10.1158\/0008-5472.CAN-09-0400","article-title":"In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer","volume":"69","author":"Ugel","year":"2009","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.mtbio.2026.103192_bib95","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.1021\/acs.nanolett.7b03734","article-title":"Biologically inspired design of nanoparticle artificial antigen-presenting cells for immunomodulation","volume":"17","author":"Hickey","year":"2017","journal-title":"Nano Lett."},{"issue":"10","key":"10.1016\/j.mtbio.2026.103192_bib96","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1021\/acs.nanolett.9b02252","article-title":"Augmentation of T-Cell activation by oscillatory forces and engineered antigen-presenting cells","volume":"19","author":"Majedi","year":"2019","journal-title":"Nano Lett."},{"issue":"48","key":"10.1016\/j.mtbio.2026.103192_bib97","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.add1106","article-title":"DNA origami-based artificial antigen-presenting cells for adoptive T cell therapy","volume":"8","author":"Sun","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mtbio.2026.103192_bib98","first-page":"160","article-title":"DNA-Based artificial dendritic cells for in situ cytotoxic T cell stimulation and immunotherapy","volume":"15","author":"Le","year":"2021","journal-title":"Bioact. Mater."},{"issue":"32","key":"10.1016\/j.mtbio.2026.103192_bib99","doi-asserted-by":"crossref","first-page":"21554","DOI":"10.1021\/acsnano.4c07306","article-title":"Spiky gold nanoparticles, a nanoscale approach to enhanced ex vivo T-Cell activation","volume":"18","author":"Esmaeili","year":"2024","journal-title":"ACS Nano"},{"issue":"34","key":"10.1016\/j.mtbio.2026.103192_bib100","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202400714","article-title":"Nucleation-inhibited emulsion interfacial assembled polydopamine microvesicles as artificial antigen-presenting cells","volume":"20","author":"Dong","year":"2024","journal-title":"Small"},{"issue":"31","key":"10.1016\/j.mtbio.2026.103192_bib101","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202309860","article-title":"Surface-functionalized microgels as artificial antigen-presenting cells to regulate expansion of T cells","volume":"36","author":"Lou","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2026.103192_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122773","article-title":"Alginate-based artificial antigen presenting cells expand functional CD8+ T cells with memory characteristics for adoptive cell therapy","volume":"313","author":"Omotoso","year":"2025","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.mtbio.2026.103192_bib103","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/ad2fd4","article-title":"Microfluidic-based preparation of artificial antigen-presenting gel droplets for integrated and minimalistic adoptive cell therapy strategies","volume":"16","author":"Tian","year":"2024","journal-title":"Biofabrication"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103192_bib66","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.nano.2013.06.015","article-title":"Nanoscale artificial antigen presenting cells for T cell immunotherapy","volume":"10","author":"Perica","year":"2014","journal-title":"Nanomedicine"},{"issue":"7","key":"10.1016\/j.mtbio.2026.103192_bib104","doi-asserted-by":"crossref","first-page":"6861","DOI":"10.1021\/acsnano.5b02829","article-title":"Enrichment and expansion with nanoscale artificial antigen presenting cells for adoptive immunotherapy","volume":"9","author":"Perica","year":"2015","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.mtbio.2026.103192_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350528","article-title":"Activation and differentiation of cognate T cells by a dextran-based antigen-presenting system for cancer immunotherapy","volume":"53","author":"Mahata","year":"2023","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103192_bib72","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006847","article-title":"TCR-Engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy","volume":"11","author":"Tvingsholm","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.mtbio.2026.103192_bib105","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00262-007-0360-x","article-title":"Potent costimulation of human CD8 T cells by anti-4-1BB and anti-CD28 on synthetic artificial antigen presenting cells","volume":"57","author":"Rudolf","year":"2008","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103192_bib106","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1182\/blood-2004-07-2940","article-title":"Cytotoxic minor histocompatibility antigen HA-1-specific CD8+ effector memory T cells: artificial APCs pave the way for clinical application by potent primary in vitro induction","volume":"106","author":"Schilbach","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.mtbio.2026.103192_bib65","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1039\/c3sc51399h","article-title":"Therapeutic nanoworms: towards novel synthetic dendritic cells for immunotherapy","volume":"4","author":"Mandal","year":"2013","journal-title":"Chem. Sci."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103192_bib107","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1021\/cb500455g","article-title":"Polymer-based synthetic dendritic cells for tailoring robust and multifunctional T cell responses","volume":"10","author":"Mandal","year":"2015","journal-title":"ACS Chem. Biol."},{"issue":"13","key":"10.1016\/j.mtbio.2026.103192_bib71","doi-asserted-by":"crossref","first-page":"12101","DOI":"10.1021\/acsnano.2c11884","article-title":"Direct in vivo activation of T cells with nanosized immunofilaments inhibits tumor growth and metastasis","volume":"17","author":"Weiss","year":"2023","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.mtbio.2026.103192_bib69","doi-asserted-by":"crossref","first-page":"15072","DOI":"10.1021\/acsnano.2c06211","article-title":"Artificial antigen-presenting cell topology dictates T cell activation","volume":"16","author":"Wauters","year":"2022","journal-title":"ACS Nano"},{"issue":"50","key":"10.1016\/j.mtbio.2026.103192_bib70","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd1631","article-title":"Size-transformable antigen-presenting cell-mimicking nanovesicles potentiate effective cancer immunotherapy","volume":"6","author":"Yang","year":"2020","journal-title":"Sci. Adv."},{"issue":"10","key":"10.1016\/j.mtbio.2026.103192_bib73","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1021\/acs.nanolett.1c00245","article-title":"Antibody-functionalized nanowires: a tuner for the activation of T cells","volume":"21","author":"Bhingardive","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.mtbio.2026.103192_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122048","article-title":"Biomimetic dendritic polymeric microspheres induce enhanced T cell activation and expansion for adoptive tumor immunotherapy","volume":"296","author":"Yang","year":"2023","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.mtbio.2026.103192_bib109","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201801188","article-title":"Cell-templated silica microparticles with supported lipid bilayers as artificial antigen-presenting cells for T cell activation","volume":"8","author":"Olden","year":"2019","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.mtbio.2026.103192_bib61","article-title":"A review of innovative design strategies: artificial antigen presenting cells in cancer immunotherapy","volume":"669","author":"Syed","year":"2025","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.mtbio.2026.103192_bib63","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1073\/pnas.1216893110","article-title":"Particle shape enhances specificity of antibody-displaying nanoparticles","volume":"110","author":"Barua","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.mtbio.2026.103192_bib110","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41568-024-00785-5","article-title":"Cross-priming in cancer immunology and immunotherapy","volume":"25","author":"Luri-Rey","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.mtbio.2026.103192_bib111","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1084\/jem.186.8.1183","article-title":"Dendritic cells as adjuvants for immune-mediated resistance to tumors","volume":"186","author":"Schuler","year":"1997","journal-title":"J. Exp. Med."},{"issue":"15","key":"10.1016\/j.mtbio.2026.103192_bib112","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1158\/1078-0432.CCR-19-1321","article-title":"Dendritic cells, the T-cell-inflamed tumor microenvironment, and immunotherapy treatment response","volume":"26","author":"Garris","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mtbio.2026.103192_bib113","article-title":"STING agonist-based ER-targeting molecules boost antigen cross-presentation","author":"Wang","year":"2025","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.mtbio.2026.103192_bib114","article-title":"Artificial mini dendritic cells boost T cell-based immunotherapy for ovarian cancer","volume":"7","author":"Cheng","year":"2020","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"5","key":"10.1016\/j.mtbio.2026.103192_bib115","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1021\/acs.nanolett.0c04783","article-title":"Engineering nanoscale artificial antigen-presenting cells by metabolic dendritic cell labeling to potentiate cancer immunotherapy","volume":"21","author":"Xiao","year":"2021","journal-title":"Nano Lett."},{"issue":"16","key":"10.1016\/j.mtbio.2026.103192_bib116","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1021\/acs.nanolett.2c01863","article-title":"Engineered macrophage-membrane-coated nanoparticles with enhanced PD-1 expression induce immunomodulation for a synergistic and targeted antiglioblastoma activity","volume":"22","author":"Yin","year":"2022","journal-title":"Nano Lett."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103192_bib117","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202208555","article-title":"Aggregation-induced-emission photosensitizer-loaded nano-superartificial dendritic cells with directly presenting tumor antigens and reversed immunosuppression for photodynamically boosted immunotherapy","volume":"35","author":"Sun","year":"2023","journal-title":"Adv. Mater."},{"issue":"47","key":"10.1016\/j.mtbio.2026.103192_bib118","doi-asserted-by":"crossref","first-page":"55890","DOI":"10.1021\/acsami.1c17498","article-title":"Immunotherapy for tumor metastasis by artificial antigen-presenting cells via targeted microenvironment regulation and T-Cell activation","volume":"13","author":"Lu","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"23","key":"10.1016\/j.mtbio.2026.103192_bib119","article-title":"Engineering an artificial T-Cell stimulating matrix for immunotherapy","volume":"31","author":"Hickey","year":"2019","journal-title":"Adv. Mater."},{"issue":"23","key":"10.1016\/j.mtbio.2026.103192_bib120","article-title":"In vivo stimulation of therapeutic antigen-specific T cells in an artificial lymph node matrix","volume":"36","author":"Livingston","year":"2024","journal-title":"Adv. Mater."},{"issue":"20","key":"10.1016\/j.mtbio.2026.103192_bib121","doi-asserted-by":"crossref","first-page":"13266","DOI":"10.1021\/acsnano.4c02425","article-title":"In situ sprayed exosome-cross-linked gel as artificial lymph nodes for postoperative glioblastoma immunotherapy","volume":"18","author":"Bao","year":"2024","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.mtbio.2026.103192_bib122","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41596-019-0249-0","article-title":"Activation and expansion of human T cells using artificial antigen-presenting cell scaffolds","volume":"15","author":"Zhang","year":"2020","journal-title":"Nat. Protoc."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103192_bib123","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nbt.4047","article-title":"Scaffolds that mimic antigen-presenting cells enable ex vivo expansion of primary T cells","volume":"36","author":"Cheung","year":"2018","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103192_bib124","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41551-024-01216-4","article-title":"Subcutaneous biodegradable scaffolds for restimulating the antitumour activity of pre-administered CAR-T cells","volume":"9","author":"Zhang","year":"2025","journal-title":"Nat. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103192_bib125","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41551-022-00977-0","article-title":"Systemic enhancement of antitumour immunity by peritumourally implanted immunomodulatory macroporous scaffolds","volume":"7","author":"Majedi","year":"2023","journal-title":"Nat. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103192_bib126","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nbt.3104","article-title":"Biopolymer implants enhance the efficacy of adoptive T-cell therapy","volume":"33","author":"Stephan","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.mtbio.2026.103192_bib127","first-page":"241","article-title":"Dendritic cell-mimicking scaffolds for ex vivo T cell expansion","volume":"21","author":"Kim","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.mtbio.2026.103192_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121972","article-title":"T cell-responsive macroporous hydrogels for in situ T cell expansion and enhanced antitumor efficacy","volume":"293","author":"Bhatta","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.mtbio.2026.103192_bib129","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jconrel.2024.04.040","article-title":"Biomaterial-based scaffolds for direct in situ programming of tumor-infiltrating T lymphocytes","volume":"370","author":"Inamdar","year":"2024","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103192_bib130","article-title":"Harnessing self-assembling peptides on \u03b3\u03b4 T cells to enhance anti-tumor immunity","author":"Liang","year":"2025","journal-title":"Polym. Sci. Technol."},{"issue":"9","key":"10.1016\/j.mtbio.2026.103192_bib131","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1021\/polymscitech.5c00119","article-title":"Engineering pyroptosis with organelle-targeted polymeric materials: toward precise cancer immunotherapy","volume":"1","author":"Zhou","year":"2025","journal-title":"Polym. Sci. Technol."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103192_bib132","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1021\/acs.biomac.5c02318","article-title":"Bioactive poly(amino acid) nanomaterials potentiate cancer immunotherapy","volume":"27","author":"Yang","year":"2026","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.mtbio.2026.103192_bib133","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.mtbio.2026.103192_bib134","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1158\/0008-5472.CAN-08-4709","article-title":"The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies","volume":"69","author":"Ozao-Choy","year":"2009","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.mtbio.2026.103192_bib135","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1021\/polymscitech.5c00110","article-title":"Immunologically effective chiral polymers to potentiate anti-cancer immune responses","volume":"1","author":"Wang","year":"2025","journal-title":"Polym. Sci. Technol."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103192_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.celbio.2026.100407","article-title":"Immunomodulatory biomaterials reprogram anti-cancer immunity","volume":"2","author":"Wang","year":"2026","journal-title":"Cell Biomater."},{"key":"10.1016\/j.mtbio.2026.103192_bib137","article-title":"Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy","author":"Witten","year":"2024","journal-title":"Nat. Biotechnol."},{"issue":"74","key":"10.1016\/j.mtbio.2026.103192_bib138","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abj9123","article-title":"Tumor microenvironmental signals reshape chromatin landscapes to limit the functional potential of exhausted T cells","volume":"7","author":"Ford","year":"2022","journal-title":"Sci. Immunol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103192_bib139","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1038\/s41467-025-60463-4","article-title":"TIM3-blockade synergizes with IL2 in alleviating intra-tumoral CD8+T cell exhaustion","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103192_bib140","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1158\/2159-8290.CD-22-0764","article-title":"Racial\/ethnic and sex differences in somatic cancer gene mutations among patients with early-onset colorectal cancer","volume":"13","author":"Holowatyj","year":"2023","journal-title":"Cancer Discov."},{"issue":"7","key":"10.1016\/j.mtbio.2026.103192_bib141","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1158\/0008-5472.CAN-24-1788","article-title":"Genomic analysis reveals racial and age-related differences in the somatic landscape of breast cancer and the association with socioeconomic factors","volume":"85","author":"Van Alsten","year":"2025","journal-title":"Cancer Res."},{"issue":"8013","key":"10.1016\/j.mtbio.2026.103192_bib142","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/s41586-024-07368-2","article-title":"Geographic variation of mutagenic exposures in kidney cancer genomes","volume":"629","author":"Senkin","year":"2024","journal-title":"Nature"},{"issue":"31","key":"10.1016\/j.mtbio.2026.103192_bib143","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1200\/JCO.2015.62.2126","article-title":"Comparison of the genomic landscape between primary breast cancer in African American versus white women and the association of racial differences with tumor recurrence","volume":"33","author":"Keenan","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103192_bib144","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1470-2045(21)00752-X","article-title":"Genetic predisposition to cancer across people of different ancestries in Qatar: a population-based, cohort study","volume":"23","author":"Saad","year":"2022","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.mtbio.2026.103192_bib145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41571-020-00460-2","article-title":"Advances in the development of personalized neoantigen-based therapeutic cancer vaccines","volume":"18","author":"Blass","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103192_bib146","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41591-024-03418-4","article-title":"Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial","volume":"31","author":"Borgers","year":"2025","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103192_bib147","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cell.2020.08.053","article-title":"A phase Ib trial of personalized neoantigen therapy plus Anti-PD-1 in patients with advanced melanoma, non-small cell lung cancer, or bladder cancer","volume":"183","author":"Ott","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.mtbio.2026.103192_bib148","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-024-01342-z","article-title":"Site-directed multivalent conjugation of antibodies to ubiquitinated payloads","author":"El Hebieshy","year":"2025","journal-title":"Nat. Biomed. Eng."}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426004369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426004369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:57:43Z","timestamp":1790063863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006426004369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":148,"alternative-id":["S2590006426004369"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103192","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered artificial antigen-presenting cells for tumor immunotherapy: Design strategies, clinical applications, and translational challenges","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103192","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103192"}}